Bios Clinical Opportunity Fund, LP — SEC Form 4 filings
SEC reporting owner CIK 1988639. 6 Form 4 filings on record with FilingPulse; latest filed 2025-06-30.
Transaction summary — filings shown
Covers all 6 filings on record, filed 2024-08-14 to 2025-06-30. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 3 legs across 2 filings — 571,428 shares, $4,499,996 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 6 legs across 2 filings — 49,998 shares, $424,983 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 59.
- Largest priced transaction: purchase of 375,000 shares @ $8.00 ($3,000,000) in ACTUATE THERAPEUTICS, INC., filed 2024-08-14.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ACTUATE THERAPEUTICS, INC. (ACTU) | Director, 10% owner | 4 | 3 legs · 571,428 sh · $4,499,996 | 6 legs · 49,998 sh · $424,983 | 52 |
| IN8BIO, INC. | 10% owner | 2 | — | — | 7 |
Form 4 filings — Bios Clinical Opportunity Fund, LP
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2025-06-30 | 4 | ACTUATE THERAPEUTICS, INC. (ACTU) jointly with Bios Equity COF, LP, Bios 2024 Co-Invest, LP, BP Directors, LP | Purchase (P): 71,428 @ $7 · Purchase (P): 71,428 (derivative) @ $0 | EDGAR |
| 2025-05-07 | 4 | IN8BIO, INC. jointly with Fletcher Aaron G.L., BIOS Fund II, LP, BIOS Fund II QP, LP, BIOS Fund II NT, LP, BIOS Incysus Co-Invest I, LP, Bios Equity COF, LP, BIOS Capital Management, LP, BIOS Advisors GP, LLC | Purchase (P): 1,148,482 (derivative) · Other (J): 574,241 (derivative) · Other (J): 574,241 (derivative) | EDGAR |
| 2024-10-11 | 4 | IN8BIO, INC. (INAB) jointly with Fletcher Aaron G.L., BIOS Fund II, LP, BIOS Fund II QP, LP, BIOS Fund II NT, LP, BIOS Incysus Co-Invest I, LP, Bios Equity COF, LP, BIOS Capital Management, LP, BIOS Advisors GP, LLC | Purchase (P): 709,040 (derivative) · Purchase (P): 709,040 (derivative) · Disposition to issuer (D): 574,241 (derivative) · Grant/award (A): 574,241 (derivative) | EDGAR |
| 2024-08-20 | 4/A | ACTUATE THERAPEUTICS, INC. (ACTU) jointly with Bios Equity COF, LP, BP Directors, LP | Sale (S): 5,314 @ $8 · Sale (S): 17,361 @ $8 · Sale (S): 2,324 @ $8 | EDGAR |
| 2024-08-14 | 4 | ACTUATE THERAPEUTICS, INC. (ACTU) jointly with Bios Equity COF, LP, BP Directors, LP | Conversion (C): 884,427 · Purchase (P): 375,000 @ $8 · Purchase (P): 125,000 @ $8 · Conversion (C): 525,797 · Conversion (C): 307,538 · Conversion (C): 141,457 · +50 more | EDGAR |
| 2024-08-14 | 4 | ACTUATE THERAPEUTICS, INC. (ACTU) jointly with Bios Equity COF, LP, BP Directors, LP | Holdings only — no transactions reported | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1988639 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →